|Articles|June 4, 2021
Common Challenges in Cross-Functional Process Development
Author(s)BioPharm International Editors
Well-defined studies are crucial to effective process development.
Advertisement
In this interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, discusses stumbling blocks to process development; strategies for developing, scaling up, and scaling out bioprocesses; and challenges when working across multiple sites.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Launch in Lockstep: Biopharma Readiness for the CNPV’s Accelerated Clock
2
How Miniaturized Analytics Are Transforming Aseptic Bioprocessing Control
3
CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns
4
Industry Experts Probe CNPV Impacts
5
